Effect of omeprazole on the secretion of intrinsic factor, gastric acid and pepsin in man
- PMID: 3924748
- PMCID: PMC1432743
- DOI: 10.1136/gut.26.6.594
Effect of omeprazole on the secretion of intrinsic factor, gastric acid and pepsin in man
Abstract
The effect of an intravenous infusion of omeprazole (0.35 mg/kg) and placebo on basal and stimulated (pentagastrin 1.0 microgram/kg/h) secretion of gastric acid, intrinsic factor and pepsin was studied in 10 healthy male subjects. Omeprazole caused a marked inhibition of basal and stimulated acid output. The inhibition of pepsin output was less marked, but also significant. The output of intrinsic factor, however, showed no significant change. The results indicate that acid and intrinsic factor might have different secretory mechanisms within the parietal cell.
Similar articles
-
Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.Drugs. 1986 Jul;32(1):15-47. doi: 10.2165/00003495-198632010-00002. Drugs. 1986. PMID: 3527658 Review.
-
Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.Gut. 1984 Jul;25(7):707-10. doi: 10.1136/gut.25.7.707. Gut. 1984. PMID: 6428981 Free PMC article.
-
Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man.Dig Dis Sci. 1984 Sep;29(9):797-801. doi: 10.1007/BF01318421. Dig Dis Sci. 1984. PMID: 6432499
-
Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily.Gut. 1985 Oct;26(10):1018-24. doi: 10.1136/gut.26.10.1018. Gut. 1985. PMID: 3932137 Free PMC article.
-
[Inhibition of H+/K+-ATPase in the parietal cell with omeprazole: a new principle of gastric acid inhibition].Ned Tijdschr Geneeskd. 1985 Apr 13;129(15):679-82. Ned Tijdschr Geneeskd. 1985. PMID: 2986019 Review. Dutch. No abstract available.
Cited by
-
Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.Drugs. 1986 Jul;32(1):15-47. doi: 10.2165/00003495-198632010-00002. Drugs. 1986. PMID: 3527658 Review.
-
Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.Dig Dis Sci. 2006 Jan;51(1):123-31. doi: 10.1007/s10620-006-3096-0. Dig Dis Sci. 2006. PMID: 16416224 Clinical Trial.
-
Pathophysiological effects of long-term acid suppression in man.Dig Dis Sci. 1995 Feb;40(2 Suppl):96S-120S. doi: 10.1007/BF02214874. Dig Dis Sci. 1995. PMID: 7859587 Review.
-
Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.Drugs. 1991 Jul;42(1):138-70. doi: 10.2165/00003495-199142010-00008. Drugs. 1991. PMID: 1718683 Review.
-
Nizatidine and gastric emptying in functional dyspepsia.Dig Dis Sci. 2008 Feb;53(2):352-7. doi: 10.1007/s10620-007-9898-x. Epub 2007 Aug 9. Dig Dis Sci. 2008. PMID: 17682943 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources